Myopia control lenses effective at 12 months but uncertain at 24 months

Spectacle lenses designed to control myopia progression show significant short-term benefits in reducing myopia progression at 12 months but lack clear long-term efficacy at 24 months, according to a study.

This systematic review analyzed 21 studies, with 17 contributing data for meta-analysis. The study analyzed outcomes at 12- and 24-month intervals using data from 6,175 participants.

At 12 months, the lenses significantly reduced myopia progression, with a pooled effect size showing improvements in spherical equivalent refraction, axial length (P < 0.0001). However, at 24 months, these benefits were not statistically significant. Relative peripheral refraction results varied across lens models.

The findings suggest that while these lenses offer short-term benefits, their long-term efficacy remains unclear.

Reference
Perea-Romero J, Signes-Soler I, Badenes-Ribera L, et al. Efficacy of spectacle lenses specifically designed for myopia control: systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2024;doi: 10.1007/s00417-024-06706-4. Epub ahead of print. PMID: 39652182.